PDF(1332 KB)
High-risk factors for early failure of high-flow nasal cannula oxygen therapy in children
LIU Jie, LI De-Yuan, LIU Zhong-Qiang, LU Guo-Yan, LI Xiao-Qing, QIAO Li-Na
Chinese Journal of Contemporary Pediatrics ›› 2019, Vol. 21 ›› Issue (7) : 650-655.
PDF(1332 KB)
PDF(1332 KB)
High-risk factors for early failure of high-flow nasal cannula oxygen therapy in children
Objective To determine the high-risk factors for early failure of high-flow nasal cannula (HFNC) oxygen therapy in children with acute respiratory insufficiency (ARI). Methods The clinical data of 123 children with ARI were reviewed who received HFNC oxygen therapy in the pediatric intensive care unit from January to June, 2018. The children who did not require an upgrade of respiratory support during hospitalization and were successfully weaned from HFNC were classified as HFNC success group (69 cases). Of the remaining children (54 cases) who required an upgrade of their respiratory support during hospitalization, those that needed to upgrade their respiratory support within 48 hours of receiving HFNC were classified as early HFNC failure group (46 cases). Risk factors for early failure of HFNC were determined using multivariate logistic regression analysis. Results The incidence rates of shock, sepsis, intracranial hypertension syndrome, and multiple organ dysfunction syndrome were significantly higher in the early HFNC failure group than in the HFNC success group (P < 0.05). Before implementation of respiratory support, the early HFNC failure group had significantly lower Glasgow coma score, pH value, and oxygenation index and significantly higher Pediatric Risk of Mortality (PRISM) score and PaCO2/PaO2 ratio than the HFNC success group (P < 0.05). Multivariate logistic regression analysis showed that PRISM score > 4.5 and PaCO2/PaO2 ratio > 0.64 were independent risk factors for early HFNC failure (OR=5.535 and 9.089 respectively; P < 0.05). Conclusions Pediatric ARI patients with PRISM score > 4.5 or PaCO2/PaO2 ratio > 0.64 have relatively high risk of early HFNC failure.
Acute respiratory insufficiency / High-flow nasal cannula oxygen therapy / Risk factor / Child
[1] Curley GF, Laffy JG, Zhang H, et al. Noninvasive respiratory support for acute respiratory failure-high flow nasal cannula oxygen or non-invasive ventilation?[J]. J Thorac Dis, 2015, 7(7):1092-1097.
[2] Taha DK, Kornhauser M, Greenspan JS, et al. High flow nasal cannula use is associated with increased morbidity and length of hospitalization in extremely low birth weight infants[J]. J Pediatr, 2016, 173:50-55.e1.
[3] 申昆玲, 江载芳. 肺炎[M]//胡亚美, 江载芳. 诸福棠实用儿科学(上册). 第7版. 北京:人民卫生出版社, 2011:1174-1177.
[4] 李昌崇. 呼吸系统疾病[M]//王卫平, 毛萌. 儿科学. 第8版. 北京:人民卫生出版社, 2014:264-266.
[5] Bischoff M. Medications for respiratory insufficiency and ex-acerbations[J]. MMW Fortschr Med, 2015, 157(4):28-29.
[6] 卢仲毅. 重要生命体征的简易监测[M]//赵祥文. 儿科急诊医学. 第3版. 北京:人民卫生出版社, 2010:1094-1096.
[7] 陈绍潞. 体液酸碱平衡失调[M]//胡亚美, 江载芳. 诸福棠实用儿科学(上册). 第7版. 北京:人民卫生出版社, 2011:391-397.
[8] 陈贤楠. 小儿急性肺损伤和呼吸窘迫综合征[M]//胡亚美, 江载芳. 诸福棠实用儿科学(下册). 第7版. 北京:人民卫生出版社, 2011:2545-2550.
[9] 董宗祈. 急性肺损伤[M]//赵祥文. 儿科急诊医学. 第3版. 北京:人民卫生出版社, 2010:502-505.
[10] 宋志芳. 小议机械通气在危重病抢救中的几个热点问题[J]. 中国危重病急救医学, 2004, 16(5):257-259.
[11] Mosier JM, Sakles JC, Whitmore SP, et al. Failed noninvasive positive-pressure ventilation is associated with an increased risk of intubation-related complications[J]. Ann Intensive Care, 2015, 5:4.
[12] Frat JP, Thille AW, Mercat A, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure[J]. N Engl J Med, 2015, 372(23):2185-2196.
[13] Roberts CT, Manley BJ, Dawson JA, et al. Nursing perceptions of high-flow nasal cannulae treatment for very preterm infants[J]. J Paediatr Child Health, 2014, 50(10):806-810.
[14] Mikalsen IB, Davis P, Øymar K. High flow nasal cannula in children:a literature review[J]. Scand J Trauma Resusc Emerg Med, 2016, 24:93.
[15] Mardegan V, Priante E, Lolli E, et al. Heated, humidified high-flow nasal cannulae as a form of noninvasive respiratory support for preterm infants and children with acute respiratory failure[J]. Am J Perinatol, 2016, 33(11):1058-1061.
[16] Manley BJ, Owen LS. High-flow nasal cannula:mechanisms, evidence and recommendations[J]. Semin Fetal Neonatal Med, 2016, 21(3):139-145.
[17] Joseph L, Goldberg S, Shitrit M, et al. High-flow nasal cannula therapy for obstructive sleep apnea in children[J]. J Clin Sleep Med, 2015, 11(9):1007-1010.
[18] Wing R, James C, Maranda LS, et al. Use of high-flow nasal cannula support in the emergency department reduces the need for intubation in pediatric acute respiratory insufficiency[J]. Pediatr Emerg Care, 2012, 28(11):1117-1123.
[19] Gaunt KA, Spilman SK, Halub ME, et al. High-flow nasal cannula in a mixed adult ICU[J]. Respir Care, 2015, 60(10):1383-1389.
[20] Ischaki E, Pantazopoulos I, Zakynthinos S. Nasal high flow therapy:a novel treatment rather than a more expensive oxygen device[J]. Eur Respir Rev, 2017, 26(145). pii:170028.
[21] Lee JS, O'Dochartaigh D, Mackenzie M, et al. Factors associated with failure of non-invasive positive pressure ventilation in a critical care helicopter emergency medical service[J]. Prehosp Disaster Med, 2015, 30(3):239-243.
[22] Pollack MM, Ruttimann UE, Getson PR. Pediatric risk of mortality (PRISM) score[J]. Crit Care Med, 1988, 16(11):1110-1116.
[23] Pollack MM, Patel KM, Ruttimann UE. PRISM Ш:an update pediatric risk of mortality score[J]. Crit Care Med, 1996, 24(5):743-752.
[24] 宋国维. 小儿危重病例评分[M]//赵祥文. 儿科急诊医学. 第3版. 北京:人民卫生出版社, 2010:242-250.
[25] Ferguson ND, Fan E, Camporota L, et al. The Berlin definition of ARDS:an expanded rationale, justification, and supplementary material[J]. Intensive Care Med, 2012, 38(10):1573-1582.
